Gene therapy for Duchenne muscular dystrophy fails in phase III trials
Jerry Mendell of Ohio State University and colleagues from seven countries reported the failure of a phase III clinical trial of gene therapy for Duchenne muscular dystrophy. In the multicenter, randomized EMBARK trial…